Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer

[1]  E. Chapman-Davis,et al.  Promoting health equity in the era of COVID-19☆ , 2020, Gynecologic Oncology.

[2]  C. Laurencin,et al.  The COVID-19 Pandemic: a Call to Action to Identify and Address Racial and Ethnic Disparities , 2020, Journal of Racial and Ethnic Health Disparities.

[3]  S. Cannistra,et al.  Challenges Faced by Medical Journals During the COVID-19 Pandemic. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Centers for Disease Control and Prevention CDC COVID-19 Response Team.  Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[5]  R. Fisher,et al.  A War on Two Fronts: Cancer Care in the Time of COVID-19 , 2020, Annals of Internal Medicine.

[6]  Zhicheng Wang,et al.  Combating COVID-19: health equity matters , 2020, Nature Medicine.

[7]  M. Chua,et al.  SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China , 2020, JAMA oncology.

[8]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[9]  Li Zhang,et al.  Risk of COVID-19 for patients with cancer , 2020, The Lancet Oncology.

[10]  Huahao Shen,et al.  Risk of COVID-19 for patients with cancer , 2020, The Lancet Oncology.

[11]  R. Redfield,et al.  Covid-19 — Navigating the Uncharted , 2020, The New England journal of medicine.

[12]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[13]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[14]  M. Frey,et al.  Bridging the Gap: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer. , 2019, Journal of oncology practice.

[15]  V. Caron,et al.  United states. , 2018, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[16]  E. Paskett,et al.  Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: Findings from the WHI LILAC study , 2018, Psycho-oncology.

[17]  J. Custers,et al.  Re‐validation and screening capacity of the 6‐item version of the Cancer Worry Scale , 2018, Psycho-oncology.

[18]  Jason D. Wright,et al.  Cost of Care for the Initial Management of Ovarian Cancer. , 2017, Obstetrics and gynecology.

[19]  Q. Wen,et al.  Mental distress, quality of life and social support in recurrent ovarian cancer patients during active chemotherapy. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[20]  M. Frey,et al.  Ovarian cancer survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum. , 2017, Gynecologic oncology.

[21]  Thorsten Kahnt,et al.  A neural link between generosity and happiness , 2017, Nature Communications.

[22]  N. Biglia,et al.  Fear of cancer recurrence in ovarian cancer survivors , 2016 .

[23]  R. Alfonso-Cristancho,et al.  The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[24]  M. Fitch,et al.  Perspectives from older adults receiving cancer treatment about the cancer-related information they receive , 2015, Asia-Pacific journal of oncology nursing.

[25]  L. Ricciardelli,et al.  Symptoms of posttraumatic stress in Australian women with ovarian cancer , 2015, Psycho-oncology.

[26]  M. Frey,et al.  A qualitative study of ovarian cancer survivors' perceptions of endpoints and goals of care. , 2014, Gynecologic oncology.

[27]  P. Newcomb,et al.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. , 2013, Health affairs.

[28]  Phyllis Butow,et al.  Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. , 2007, Gynecologic oncology.

[29]  N. Tarrier,et al.  Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study. , 2004, British journal of health psychology.

[30]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Huston Gj,et al.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[32]  C. Dickens,et al.  Cancer Information and Support Centres: fixing parts cancer drugs cannot reach. , 2007, European journal of cancer care.